Summary :
The potential for dietary fat to interfere with the development of breast cancer by delaying its occurrence makes identification of defined molecules a mandatory step in cancer prevention. In order to circumvent the limitations and/or bias of dietary exposure assessment tools, biomarkers of past lipid intake such as the fatty acid composition of white adipose tissue have been used. When considered separately, candidate fatty acids identified as favorable on the basis of their association with breast cancer risk have usually led to inconsistent results in animal intervention studies. This inconsistency indicates that any approach based on a single fatty acid should be abandoned for an integrated view over the complex lipid interactions which finally determines the lipidome, the lipid profile that is found in individuals. This article presents a reappraisal of the role of the lipid profile through a comprehensive reanalysis of adipose tissue fatty acid composition obtained in patients with benign or malignant breast tumors as well as in experimental animals during dietary interventions. Rather than a single fatty acid, a composite indicator combining elevated monounsaturates and low ω6/ω3 fatty acid ratio was associated with breast cancer protection. This lipidome may become the template for identifying breast cancer risk related to diet, and for designing proper dietary modifications to delay the occurrence of breast cancer, although the universality of the findings cannot be assessed from a single study. Numerous epidemiological studies have established striking geographic differences in the rate of incidence of breast cancer, and those conducted in migrant populations strongly support a role for environmental exposure including diet in the variation of breast cancer rates across countries [1] . Indeed, it has been suggested that 20 to 60 % of cancer, depending on the anatomic localization of the tumor, may be avoidable by altering the diet [2] . Among several dietary components that could modulate breast cancer risk, fat has been extensively examined with little evidence for a promoting effect of total fat intake independent of the fat contribution to total energy intake [3] , total energy intake which has been recently shown to be positively associated with breast cancer risk in Chinese women [4] . Ecological, cohort, and case-control studies aimed at evaluating the association between usual or past diet assessed by either dietary recall, dietary record, dietary interview, food frequency questionnaire on the one hand, and breast cancer risk on the other hand have led to discordant conclusions [5] . The discrepancies between studies are mainly due to the limitations and/or bias of dietary exposure assessment tools, including subjectivity, unintentional inaccuracy, underreporting, and dieting behavior which alter the quality of dietary data collected in free-living populations [6] . Beyond the uncertainties that are common to any study of nutritional epidemiology, there are specific limitations in evaluating the intake of some dietary fatty acids which are partly or totally excluded from food composition tables currently available. This is usually the case for the fatty acids quantitatively considered as minor, but which are biologically important, including long-chain polyunsaturated fatty acids (PUFA) of the ω3 and ω6 series, trans fatty acids, and conjugated linoleic acid, for instance. emphasis on ω3 and ω6 PUFA. Briefly, studies dealing with the ω3-ω6 PUFA composition of either serum or erythrocyte membrane phospholipids and breast cancer risk were inconclusive [7] . It should be stressed that plasma and membrane phospholipid composition vary according to recent dietary intakes which might be altered by the occurrence of cancer. Conversely, the fatty acid composition of WAT triglycerides best reflects past dietary intake for the essential fatty acids (linoleic acid, α-linolenic acid, and long-chain ω3 PUFA) [8] [9] , and appears to be a more relevant marker of lasting exposure with respect to the breast cancer risk and fat intake relationships. This marker has been used in several studies aiming to investigate the relation between exposure to ω3 and ω6 PUFA and breast cancer. In our case-control study published in 2002 [10] and conducted in 241 patients with invasive breast carcinoma and 88 control patients with benign breast disease, we found significant inverse association between individual levels of α-linolenic acid and docosahexaenoic acid (DHA) in breast adipose tissue and the risk of breast cancer, with the strongest inverse association found for the ratio of long-chain ω3 PUFA to ω6 PUFA. The results of other studies have been reviewed recently with the overall conclusion that the protective effect of ω3 PUFA on breast cancer risk depends on background levels of ω6 PUFA [7] .
Intervention studies targeted on single fatty acids : a repeated failure
To fully interpret the information that the biomarkers (i.e., the WAT content of α-linolenic acid, DHA and ω6 to ω3 PUFA ratio) can provide with respect to cancer risk and possible prevention in humans, dietary interventions targeted at either α-linolenic acid or DHA were set up in NMU and DMBA-induced mammary tumor models in rats with inconsistent results [7] . Whereas some studies appeared to support the epidemiological evidence concerning the importance of the ratio of ω6 to ω3 PUFA in mammary tumor growth [11] [12] [13] , others failed [14] [15] [16] , perhaps because of the inhibitory effect of ω3 PUFA on mammary tumor growth, which depends upon background levels of ω6 PUFA and also on antioxidants levels [17] . An experimental study on rats showed that addition of vitamin E to a 15% linseed oil diet rich in α-linolenic acid led to an increase in tumor growth compared to controls without vitamin E, whereas addition of a prooxidant compound (sodium ascorbate/2-methyl-1,4-naphtoquinone) led to a decrease in tumor growth [18] . Thus, despite the identification through epidemiological studies of a few WAT fatty acids as a biomarker of breast cancer risk in humans, a more complex picture is emerging from the experimental dietary intervention studies focusing on those fatty acids.
Breast cancer risk varies depending on the WAT fatty acid level considered
To get a more integrated view of the complex lipid interactions which, in turn, give rise to the individual lipid profile in WAT triglycerides, we retrospectively reconsidered the statistical analysis of hundreds of WAT fatty acid composition previously obtained from French women with either breast cancer or benign breast tumor [10] , using principal component analysis. Secondly, we re-examined the conclusions drawn from our previous dietary intervention studies in rodents [16, 20] in the light of the new and more sophisticated analysis of human data. Figure 1 shows the adjusted odds ratios of breast cancer for the fatty acids of white adipose tissue sampled from 329 women and presented by lipid class. A decreased risk of breast cancer was associated with higher content of ω3 PUFA, either α-linolenate or the long chain ω3 fatty acids EPA or DHA. In contrast, a high content of ω6 PUFA was associated with either a trend (linoleic acid, 18:2ω6) or an increased risk (20:2ω6). Cis-monounsaturates were all protective, whereas trans-monounsaturates were not (t-16:1ω7), or were strongly associated with an increased risk (elaidic acid, t-18:1ω9). No association with breast cancer risk was detected for saturates.
WAT fatty acid levels are not independent variables
The significance of such associations is unclear when one considers the common metabolic pathways shared by numerous fatty acids which link the content of individual fatty acid to each other. Figures 2b, 2c, and 2d) and for many others (data not shown). Consequently, a single fatty acid can not be considered as an independent biomarker of breast cancer risk, and there is a need to simplify this complex system of correlations into a smaller number of dimensions.
Simplifying through principal component analysis
For this purpose, we performed a principal component analysis using our whole database of 
Failure of dietary interventions targeted on a single fatty acid in modifying favorably the lipidome in rats
On the basis of this new composite biomarker of a low risk for breast cancer -i.e., low ω6/ω3 ratio and high cis-monounsaturates-it was tempting to look back to the changes in fatty acid composition of WAT that we induced in our dietary interventions targeted at either α-linolenic acid or DHA in NMU-induced mammary tumor in rats. Table 1 summarizes the fatty acid composition of WAT triacylglycerols with or without dietary intervention over 26 weeks [16, 20] . In both diets, a significant increase in the specific ω3 fatty acid added to the control diet is obtained with a decrease in the ω6/ω3 ratio as expected. However, despite this change in the ω6/ω3 ratio, which seems to fit the appropriate direction with respect to breast cancer risk, a concomitant and significant drop in monounsaturates was induced. This drop is exactly in the opposite direction acid exposure was not achieved in these animal studies, stressing the need for a composite dietary modification rather than for single nutrient intervention.
Conclusions and future prospects
It should be pointed out that the validation of any link between a biomarker and the emergence of any type of cancer requires parallel experimental animal and human studies. An appropriate animal model is usually set up to determine the role of the marker, whether associative or causal, in the disease pathway and to establish the dose-effect relationship. Thus, to fully interpret the informations provided by the analysis of the lipidome with respect to breast cancer risk, appropriate dietary intervention reproducing two prominent features of the Mediterranean diet,
i.e., a low ω6/ω3 PUFA ratio and elevated monounsaturates levels, must be carried out in animal models and human pilot studies in the future. If successfully implemented in an appropriate model of breast cancer in rat, one may speculate that the Mediterranean-diet would bring as much comprehensive knowledge for dietary exposure and cancer relationships as did the "cafeteria" diet for the diet and obesity relationship. The reappraisal of the role of the environmental exposure to dietary fatty acids in breast cancer risk must be performed before public health applications based on the concept of cancer prevention by delay [22] , either primary or secondary, can be considered.
The lipidome may be the most appropriate mean to address this challenge. The use of the composite biomarker (OR) defined by the analysis of the lipidome provides a way to individualize women with a high risk of breast cancer due to dietary habits and to follow the impact of dietary interventions in those women. Such new approach would be even more opportune in women with genetic predisposition to breast cancer. However, the universality of our findings cannot be assessed from a single study and a confirmation is needed from studies in which the lipidome is derived from adipose tissue of women living in countries where the breast cancer incidence and dietary fat intake differs strongly from that of the French women. 
